Assessment of dissolvable microneedle technology along with Identification of Top Licensing Partner Companies through Secondary and Primary Intelligence.
A large client based in the USA, involved in drug delivery devices, with effective marketing and commercialisation presence across the globe, wanted to in-license potential dMTS based drug delivery asset from companies involved in microneedle technology research for delivering therapeutic products. They wished to identify and assess the technological competencies, clinical capabilities and commercial readiness of potential companies with a novel and non-invasive way of delivering drugs, which can include a variety of drugs/vaccines in their patch and successfully develop the product for commercial purposes, were of client’s interest.
Providing scientific innovation a boost towards clinical development and commercial milestone achievement
Achieve Breakthroughs with all-encompassing Market Outlook Research